Kết quả tìm kiếm - Jinghui Dong

  • Đang hiển thị 1 - 18 kết quả của 18
Tinh chỉnh kết quả
  1. 1
    Astrocyte control of synaptic NMDA receptors contributes to the progressive development of temporal lobe epilepsy

    Astrocyte control of synaptic NMDA receptors contributes to the progressive development of temporal lobe epilepsy Bằng Jérôme Clasadonte, Jinghui Dong, Dustin J. Hines, Philip G. Haydon

    Được phát hành 2013
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Hydrogen Sulfide Improves Endothelial Dysfunction via Downregulating BMP4/COX‐2 Pathway in Rats with Hypertension

    Hydrogen Sulfide Improves Endothelial Dysfunction via Downregulating BMP4/COX‐2 Pathway in Rats with Hypertension Bằng Lin Xiao, Jinghui Dong, Sheng Jin, Hongmei Xue, Qi Guo, Xu Teng, Yuming Wu

    Được phát hành 2016
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Ginsenoside <scp>R</scp>b3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats

    Ginsenoside <scp>R</scp>b3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats Bằng Youhua Wang, Jinghui Dong, Ping Liu, Chi Wai Lau, Zhen Gao, Zhou Duan, Jingyi Tang, Chi‐Fai Ng, Yü Huang

    Được phát hành 2014
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Selective induction of astrocytic gliosis generates deficits in neuronal inhibition

    Selective induction of astrocytic gliosis generates deficits in neuronal inhibition Bằng Pavel I. Ortinski, Jinghui Dong, Alison E. Mungenast, Cuiyong Yue, Hajime Takano, Deborah Watson, Philip G. Haydon, Douglas A. Coulter

    Được phát hành 2010
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2

    Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2 Bằng Yuhuan Xu, Jinghui Dong, Weimin An, Xiao-Yan Lv, Xiaoping Yin, Jianzeng Zhang, Li Dong, Xi Ma, Hongjie Zhang, Bu‐Lang Gao

    Được phát hành 2020
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress

    Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress Bằng Jinghui Dong, Siu Ling Wong, Chi Wai Lau, Hung Kay Lee, Chi‐Fai Ng, Lihong Zhang, Xiaoqiang Yao, Zhen‐Yu Chen, Paul M. Vanhoutte, Yü Huang

    Được phát hành 2012
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Deep learning-based automatic segmentation for size and volumetric measurement of breast cancer on magnetic resonance imaging

    Deep learning-based automatic segmentation for size and volumetric measurement of breast cancer on magnetic resonance imaging Bằng Wenyi Yue, Hongtao Zhang, Juan Zhou, Guang Li, Zhe Tang, Zeyu Sun, Jianming Cai, Ning Tian, Shen Gao, Jinghui Dong, Yuan Liu, Xu Bai, Fugeng Sheng

    Được phát hành 2022
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19

    Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19 Bằng De Chang, Peng Zhao, Dawei Zhang, Jinghui Dong, Zhe Xu, Guang Yang, Boyu Li, Hongxia Liu, Boan Li, Cheng‐Feng Qin, Xiaohua Peng, Fu‐Sheng Wang, Lixin Xie, Chen Zhu, Charles S. Dela Cruz, Lokesh Sharma, Enqiang Qin

    Được phát hành 2020
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  9. 9
    Pathological findings of COVID-19 associated with acute respiratory distress syndrome

    Pathological findings of COVID-19 associated with acute respiratory distress syndrome Bằng Zhe Xu, Lei Shi, Yijin Wang, Jiyuan Zhang, Lei Huang, Chao Zhang, Shuhong Liu, Peng Zhao, Hongxia Liu, Li Zhu, Yanhong Tai, Changqing Bai, Tingting Gao, Jin‐Wen Song, Peng Xia, Jinghui Dong, Jingmin Zhao, Fu‐Sheng Wang

    Được phát hành 2020
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  10. 10
    Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial

    Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial Bằng Sattva S. Neelapu, Michael Dickinson, Javier Muñoz, Matthew L. Ulrickson, Catherine Thiéblemont, Olalekan O. Oluwole, Alex F. Herrera, Chaitra S. Ujjani, Yi Lin, Peter A. Riedell, Natasha Kekre, Sven de Vos, Christine Lui, Francesca Milletti, Jinghui Dong, Hairong Xu, Julio C. Chávez

    Được phát hành 2022
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  11. 11
    Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial

    Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial Bằng Lei Shi, Xin Yuan, Weiqi Yao, Siyu Wang, Chao Zhang, Bo Zhang, Jin‐Wen Song, Lei Huang, Zhe Xu, Junliang Fu, Yuanyuan Li, Ruonan Xu, Tiantian Li, Jinghui Dong, Jianming Cai, Genshi Li, Yunbo Xie, Ming Shi, Yonggang Li, Yu Zhang, Wei‐Fen Xie, Fu‐Sheng Wang

    Được phát hành 2021
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  12. 12
    Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma

    Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma Bằng Max S. Topp, Tom van Meerten, Roch Houot, Monique C. Minnema, Krimo Bouabdallah, Pieternella J. Lugtenburg, Catherine Thiéblemont, Martin Wermke, Kevin Song, Irit Avivi, John Kuruvilla, Ulrich Dührsen, Yan Zheng, Saran Vardhanabhuti, Jinghui Dong, Adrian Bot, John M. Rossi, Vicki Plaks, Marika Sherman, Jenny J. Kim, A. Kerber, Marie José Kersten

    Được phát hành 2021
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  13. 13
    Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial

    Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial Bằng Tiantian Li, Bo Zhang, Hui Fang, Ming Shi, Weiqi Yao, Yuanyuan Li, Chao Zhang, Jin‐Wen Song, Lei Huang, Zhe Xu, Xin Yuan, Junliang Fu, Cheng Zhen, Yu Zhang, Ze-Rui Wang, Ziying Zhang, Mengqi Yuan, Tengyun Dong, Ruidan Bai, Lulu Zhao, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei‐Fen Xie, Yonggang Li, Lei Shi, Fu‐Sheng Wang

    Được phát hành 2023
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  14. 14
    Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial

    Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial Bằng Mengqi Yuan, Le Song, Ze-Rui Wang, Ziying Zhang, Ming Shi, Junli He, Qiong Mo, Ning Zheng, Weiqi Yao, Yu Zhang, Tengyun Dong, Yuanyuan Li, Chao Zhang, Jin‐Wen Song, Lei Huang, Zhe Xu, Xin Yuan, Junliang Fu, Cheng Zhen, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei‐Fen Xie, Yonggang Li, Bo Zhang, Lei Shi, Fu‐Sheng Wang

    Được phát hành 2025
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  15. 15
    Long-Term (≥4 Year and ≥5 Year) Overall Survival (OS) By 12- and 24-Month Event-Free Survival (EFS): An Updated Analysis of ZUMA-1, the Pivotal Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Refractory Large B-Cell Lymphoma (LBCL)

    Long-Term (≥4 Year and ≥5 Year) Overall Survival (OS) By 12- and 24-Month Event-Free Survival (EFS): An Updated Analysis of ZUMA-1, the Pivotal Study of Axicabtagene Ciloleucel (Ax... Bằng Caron A. Jacobson, Frederick L. Locke, Armin Ghobadi, David B. Miklos, Lazaros J. Lekakis, Olalekan O. Oluwole, Yi Lin, Brian T. Hill, John M. Timmerman, Abhinav Deol, Patrick M. Reagan, Patrick J. Stiff, Ian W. Flinn, Umar Farooq, André Goy, Javier Muñoz, Tanya Siddiqi, Rhine R. Shen, Adrian Bot, Jinghui Dong, Kanwarjit Singh, Clare Spooner, Roshan Karalliyadda, Jenny J. Kim, Yan Zheng, Sattva S. Neelapu

    Được phát hành 2021
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  16. 16
    Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

    Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external hist... Bằng Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick J. Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot

    Được phát hành 2022
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  17. 17
    KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

    KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study Bằng Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick J. Stiff, Deepa Jeyakumar, Chaoling Feng, Jinghui Dong, Tong Shen, Francesca Milletti, John M. Rossi, Remus Vezan, Behzad Kharabi Masouleh, Roch Houot

    Được phát hành 2021
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  18. 18
    5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1)

    5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1) Bằng Sattva S. Neelapu, Caron A. Jacobson, Armin Ghobadi, David B. Miklos, Lazaros J. Lekakis, Olalekan O. Oluwole, Yi Lin, Ira Braunschweig, Brian T. Hill, John M. Timmerman, Abhinav Deol, Patrick M. Reagan, Patrick J. Stiff, Ian W. Flinn, Umar Farooq, André Goy, Peter A. McSweeney, Javier Muñoz, Tanya Siddiqi, Julio C. Chávez, Alex F. Herrera, Nancy L. Bartlett, Adrian A. Bot, Rhine R. Shen, Jinghui Dong, Kanwarjit Singh, Harry Miao, Jenny J. Kim, Yan Zheng, Frederick L. Locke

    Được phát hành 2023
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: